Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Conference Roundup > Unique clinical patterns emerge in pediatric thyroid eye disease cases
  • Conference Roundup

Unique clinical patterns emerge in pediatric thyroid eye disease cases

Ophthalmology 360

Pediatric thyroid eye disease (TED) exhibits distinct clinical features compared to adult TED, according to a poster presented at AAO 2023, which found that lower eyelid retraction is much more common in pediatric TED cases.

The study also highlights the significant correlation between thyroid receptor antibody (TRAB) positivity and the presence of lower eyelid retraction and acquired epiblepharon in pediatric TED patients.

The study identified a total of 35 cases of pediatric TED, with an average age of 12.7 years. Among the patients, 86% presented with hyperthyroidism, and 77% were found to be positive for TRAB.

Eyelid retraction was the most prevalent symptom, observed in 94% of the cases, with scleral show (lower > upper) and acquired epiblepharon present in 69% of patients. Additionally, conjunctival injection was noted in 54% of cases, while proptosis was seen in 26%.

Principal component analysis revealed a significant correlation between TRAB-positivity and the presence of lower eyelid retraction and acquired epiblepharon. This finding underscores the importance of TRAB in understanding and diagnosing pediatric TED.

Reference
Boniao EL, et al. Beyond Upper Lid Retraction: The Importance of Lower Eyelid Retraction and Acquired Epiblepharon in Pediatric TED. Poster Presented at: AAO 2023.

Share

Related Content

  • Oculoplastics

Pain measures may help track treatment response in Graves’ orbitopathy

FDA approves Eysuvis for short-term treatment of dry eye disease
  • Oculoplastics

FDA approves Lumvoa for active and chronic thyroid eye disease

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Glaucoma

Review finds low adverse event rates for glaucoma stents

  • Retina

Switching to aflibercept 8 mg extends treatment intervals in suboptimal nARMD responders

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon